Abstract
Hypertrophic scars (HSs) develop due to excessive collagen deposition and abnormal fibroblast proliferation during wound healing, significantly impacting patient quality of life. Three dosages of GA ointments were administered to rabbit ear HS models to investigate the potential efficacy and mechanism of gallic acid (GA) on HS. Daily application of ointment was performed on the matrix group, the GA ointment groups, and the silicone gel group for 28 days. (No drug treatment was performed on the skin and model groups as a blank group and vehicle group, and silicone gel ointment was topically administered to the silicone gel group as a positive control group.) Scar specimens were collected for histopathology analysis, RNA sequencing analysis, real-time quantitative polymerase chain reaction, and Western blot analysis at the first, second, and fourth weeks after the treatment. Low-dose and medium-dose GA effectively suppressed HS formation and markedly decreased fibroblast infiltration levels and scar thickness. Moreover, decreased expression of TRPC3 mRNA and TGF-β1, p-Smad2/3, and Smad2/3 protein was observed in the low- and medium-dose GA groups and the silicone gel group. This study provides evidence for the efficacy of GA in treating HS and sheds light on its potential underlying pharmacological mechanisms.
Funding Information
  • National Natural Science Foundation of China (81974570, 82205125, 20224Y0224, 2022-38, 2021LK037, 2021-ZY-03)
  • Health Industry Clinical Research Special Project of Shanghai Municipal Health Commission (81974570, 82205125, 20224Y0224, 2022-38, 2021LK037, 2021-ZY-03)
  • Shanghai “Rising Stars of Medical Talent Youth Development Program for Youth Medical Talents-Specialist Program” (81974570, 82205125, 20224Y0224, 2022-38, 2021LK037, 2021-ZY-03)
  • Research on New Carrier Technology Development of Skin Barrier Repair Nursing Agent-Horizontal Project (81974570, 82205125, 20224Y0224, 2022-38, 2021LK037, 2021-ZY-03)
  • Budgeted Fund of Shanghai University of Traditional Chinese Medicine (Natural Science) (81974570, 82205125, 20224Y0224, 2022-38, 2021LK037, 2021-ZY-03)
  • Open Project of Qinghai Province Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation (81974570, 82205125, 20224Y0224, 2022-38, 2021LK037, 2021-ZY-03)

This publication has 54 references indexed in Scilit: